Skip to main content
. 2022 Apr 7;13(4):9387–9396. doi: 10.1080/21655979.2022.2055699

Figure 3.

Figure 3.

Omarigliptin treatment improves Y-maze test of STZ-challenged diabetic mice. Y-maze test was shown (***, P < 0.001 vs. vehicle group; #, ##, P < 0.05, 0.01 vs. STZ group).